Glucagon-like peptide-1 receptor agonists do not decrease the risk of coronary revascularization in patients with type 2 diabetes
Author:
Patoulias Dimitrios,Papadopoulos Christodoulos,Kassimis George,Doumas Michael
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,General Medicine